Clinical Trials Directory

Trials / Conditions / Stage III Fallopian Tube Cancer AJCC v7

Stage III Fallopian Tube Cancer AJCC v7

9 registered clinical trials studyying Stage III Fallopian Tube Cancer AJCC v7.

StatusTrialSponsorPhase
CompletedRuxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian,
NCT02713386
NRG OncologyPhase 1 / Phase 2
WithdrawnWeb-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With
NCT03902379
Rutgers, The State University of New JerseyN/A
Active Not RecruitingMatched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontl
NCT02726997
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedPembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal,
NCT02520154
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingAdavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary P
NCT02659241
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedTalazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tu
NCT02316834
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedEpacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopia
NCT02042430
National Cancer Institute (NCI)EARLY_Phase 1
Active Not RecruitingSurgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopi
NCT01970722
City of Hope Medical CenterPhase 1
CompletedPropranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian
NCT01504126
M.D. Anderson Cancer CenterEARLY_Phase 1